Key takeaway
Pooling four systematic reviews covering 29 unique trials, telehealth interventions lowered HbA1c by a small but significant amount compared with usual care in adults with type 2 diabetes (mean difference -0.55, 95% CI -0.73 to -0.36). This is a review of reviews with variable trial quality, and the authors themselves call for better primary studies.
Study design
Trial meta-analysis
Reading basis
Published abstract
Reading focus
Design & applicability
The research question
Telehealth is increasingly used to monitor people with type 2 diabetes, but existing systematic reviews give variable results, so the true size of the effect on blood sugar control is unclear. The authors pooled the reviews to estimate the effect on HbA1c.
Who and how
Systematic review and meta-analysis of systematic reviews of randomised controlled trials. The Cochrane Library, MEDLINE, EMBASE, HMIC and PsychINFO were searched for systematic reviews published between 1990 and April 2016, supplemented by reference searches. Two independent reviewers selected and reviewed the eligible studies. Of the 3279 references retrieved, 4 systematic reviews reporting a total of 29 unique studies were included. Both conventional pairwise and network meta-analyses were performed.
What it found
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Telehealth interventions produced a small but significant improvement in HbA1c compared with usual care (mean difference -0.55, 95% CI -0.73 to -0.36).
- 2The greatest effect was seen with telephone-delivered interventions.
- 3Internet blood glucose monitoring systems came next, and interventions with automatic transmission of self-monitored blood glucose (SMBG) through a mobile phone or telehealth unit had the smallest effect.
- 4The authors conclude that telehealth appears effective for HbA1c control, but better quality primary studies and reviews are needed to be confident.
Limits & uncertainty
- 1Only 4 reviews and 29 unique studies were included, and the search ended in April 2016, so newer trials are missing.
- 2A review of reviews inherits the weaknesses of the underlying trials, and the abstract does not report their quality or heterogeneity.
- 3The abstract gives no numbers for the differences between intervention types, so the ranking may not be statistically reliable.
- 4This reading is based on the abstract only.
What to take from it
A mean HbA1c difference of -0.55 may matter over time, but how it affects health outcomes is not shown here. Telehealth support seems to add to usual care for many people with type 2 diabetes, and whether it suits you is a decision for you and your care team.
Reading your own data
If you use a glucose meter, CGM or an app that sends readings to your care team, keep measurements consistent and review trends with your clinician rather than reacting to single values. HbA1c itself comes from a lab test and is not something a wearable measures.
How to read this evidence
Pooling trials can improve precision, but compare populations, controls, bias and uncertainty. Network rankings include indirect evidence and do not identify a universal best treatment.
Authors’ structured abstract English
The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.
Background
There is a growing body of evidence to support the use of telehealth in monitoring HbA1c levels in people living with type 2 diabetes. However, the overall magnitude of effect is yet unclear due to variable results reported in existing systematic reviews. The objective of this study is to conduct a systematic review and meta-analysis of systematic reviews of randomised controlled trials to create an evidence-base for the effectiveness of telehealth interventions on glycemic control in adults with type 2 diabetes.
Methods
Electronic databases including The Cochrane Library, MEDLINE, EMBASE, HMIC, and PsychINFO were searched to identify relevant systematic reviews published between 1990 and April 2016, supplemented by references search from the relevant reviews. Two independent reviewers selected and reviewed the eligible studies. Of the 3279 references retrieved, 4 systematic reviews reporting in total 29 unique studies relevant to our review were included. Both conventional pairwise meta-analyses and network meta-analyses were performed.
Results
Evidence from pooling four systematic reviews found that telehealth interventions produced a small but significant improvement in HbA1c levels compared with usual care (MD: -0.55, 95% CI: -0.73 to - 0.36). The greatest effect was seen in telephone-delivered interventions, followed by Internet blood glucose monitoring system interventions and lastly interventions involving automatic transmission of SMBG using a mobile phone or a telehealth unit.
Conclusion
Current evidence suggests that telehealth is effective in controlling HbA1c levels in people living with type 2 diabetes. However there is need for better quality primary studies as well as systematic reviews of RCTs in order to confidently conclude on the impact of telehealth on glycemic control in type 2 diabetes.
Sources & attribution
The impact of telehealth remote patient monitoring on glycemic control in type 2 diabetes: a systematic review and meta-analysis of systematic reviews of randomised controlled trials.
Lee PA, Greenfield G, Pappas Y.
BMC health services research · 2018-06-26
DOI: 10.1186/s12913-018-3274-8 ↗PubMed · 29940936 ↗Europe PMC · Recorded licence: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
MoveVitals editorial interpretation · educational content · no individual clinical review recorded
Sources checked 2026-11-01
Practical guides
Read in context
Early time-restricted eating linked to more weight loss and lower insulin than late eating
Pooling 41 randomised trials (2287 participants, median intervention 8 weeks), time-restricted eating was associated with 2.15 kg lower body weight than usual diets (95% CI -2.56 to -1.74), and eating early beat eating late by 1.15 kg (95% CI -1.86 to -0.45). Most trials were short, only 6 study arms tested early eating, and the outcomes were body and blood measures, not heart attacks or deaths.
BMJ Medicine
An 8 a.m. to 4 p.m. eating window added to calorie cutting gave no clear extra weight loss
Among 139 patients with obesity on a calorie-restricted diet, adding an eating window of 8:00 a.m. to 4:00 p.m. led to a mean 12-month weight change of -8.0 kg, versus -6.3 kg with calorie restriction alone. The net difference of -1.8 kg (95% CI -4.0 to 0.4; P = 0.11) was not statistically significant, and the interval cannot rule out either a real benefit or none.
The New England Journal of Medicine
In a 20-person ward trial, an ultra-processed menu led to more eating and weight gain
In 20 adults living in a hospital research unit for 28 days, an ultra-processed menu led them to eat 508 kcal/day more (± 106 SE, P = 0.0001) and gain 0.9 kg, while a menu of unprocessed foods led to a 0.9 kg loss, each over 2 weeks and with eating left to appetite. The study was small, short and fully provisioned, so it cannot show what happens in daily life or which feature of the foods drove the extra eating.
Cell Metabolism
Mediterranean diet with olive oil or nuts linked to fewer heart events (corrected trial)
Among 7447 Spanish adults aged 55 to 80 at high cardiovascular risk, those assigned to a Mediterranean diet with extra-virgin olive oil (HR 0.69, 95% CI 0.53 to 0.91) or with nuts (HR 0.72, 0.54 to 0.95) had fewer major cardiovascular events than those told to cut dietary fat. The trial had randomisation errors, which is why the 2013 report was withdrawn and the estimates recalculated, so treat this as strong but imperfect evidence.
The New England Journal of Medicine

